<DOC>
	<DOCNO>NCT02439190</DOCNO>
	<brief_summary>The purpose study determine whether BMS-986120 , aspirin , aspirin clopidogrel decrease blood clotting .</brief_summary>
	<brief_title>CV004-007 Thrombosis Chamber Study</brief_title>
	<detailed_description />
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<criteria>For information regard BMS clinical trial participation , please visit www.BMSStudyConnect.com Healthy subject determine clinically significant deviation normal medical history , physical examination , ECGs clinical laboratory determination Body Mass Index ( BMI ) 18 32 kg/m2 inclusive . BMI = weight ( kg ) / [ height ( ) ] 2 Females childbearing potential ( i.e. , postmenopausal surgically sterile ) men age 18 65 , inclusive Azoospermic male woman childbearing potential ( i.e . postmenopausal surgically sterile ; see section 3.3.3 definition WOCBP ) exempt contraceptive requirement . However , woman must still undergo pregnancy test described section Evidence organ dysfunction clinically significant deviation normal physical examination , vital sign , ECG clinical laboratory determination beyond consistent target population Any condition could affect drug absorption Other protocoldefined exclusion criterion could apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>